EGFR Positive UK
Home News Contact
Donate
Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are Inclusion and Diversity Our Policies Annual Report 2023/24
What is EGFR? Treatment Options Glossary
EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources
Donating Fundraising
Home About Us Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are Inclusion and Diversity Our Policies Annual Report 2023/24 About EGFR What is EGFR? Treatment Options Glossary Patient Support EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources NewsContact Get Involved Donating Fundraising
EGFR Positive UK
Offering hope & learning for those with EGFR+
Donate

Osimertinib approved for treating EGFR mutation positive NSCLC

 

Evidence-based recommendations on osimertinib (Tagrisso) for treating epidermal growth factor receptor (EGFR) T790M mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults.

Read more on the National Institute for Care and Health Excellence website

EGFR PositiveOctober 14, 2020
Facebook0 Twitter LinkedIn0 Reddit Tumblr Pinterest0 0 Likes
Previous

Osimertinib approved for untreated EGFR mutation-positive NSCLC

EGFR PositiveOctober 14, 2020
Next

Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC

Guest UserJune 10, 2020

The latest news

News
Lung Cancer Awareness Month 2024 Update!
Dec 13, 2024
Lung Cancer Awareness Month 2024 Update!
Dec 13, 2024
Read More →
Dec 13, 2024
NEW Clinical Trial for EGFR Exon 20 insertion mutation now open
Oct 8, 2024
NEW Clinical Trial for EGFR Exon 20 insertion mutation now open
Oct 8, 2024
Read More →
Oct 8, 2024
ESMO Congress 2024 Round-up
Oct 5, 2024
ESMO Congress 2024 Round-up
Oct 5, 2024
Read More →
Oct 5, 2024
Farewell from Angela Terry: Reflecting on (nearly) 5 Years of Service
Oct 1, 2024
Farewell from Angela Terry: Reflecting on (nearly) 5 Years of Service
Oct 1, 2024
Read More →
Oct 1, 2024
EGFR+ UK has become a member of Lung Cancer Europe
Aug 15, 2024
EGFR+ UK has become a member of Lung Cancer Europe
Aug 15, 2024
Read More →
Aug 15, 2024
Celebrating 20 Years of Scientific Progress in Treating EGFR+
Jul 27, 2024
Celebrating 20 Years of Scientific Progress in Treating EGFR+
Jul 27, 2024
Read More →
Jul 27, 2024

EGFR+ UK are proud members of Lung Cancer Europe

 
 

NEW! Follow us on Bluesky 🦋

 
 
Last Sunday, @robinwhalley_editor completed the Valencia Marathon! 🏃‍♂️ He took on this huge challenge in support of his partner, @sarahli_li, who’s living with stage 3 EGFR+ lung cancer, and to raise funds for the @uclhcancerfund and @eg
We’ve teamed up with Francesca from @francescaloves_uk to create these stunning bespoke EGFR+ bracelets! 💜💚 Featuring white seed beads (for lung cancer awareness), purple and green gems (for EGFR+ UK), and a silver “hope” charm.*
Last Tuesday’s Meet the Expert session with Anne-Marie Baird, President of Lung Cancer Europe, is now available to watch on our video page (link in bio). Anne-Marie shared an in-depth look at EGFR+ lung cancer, explaining how it mutates, treat
Last week, our brilliant new trustee Charlie went to the Cancer: Project Zero event, hosted by @astrazeneca UK. The theme, “Faster, Further, Together,” focused on how we can transform cancer outcomes through collaboration, better early di

Medical Disclaimer

The contents of this website are for informational purposes. The content is NOT a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified professional with any question you have regarding a medical condition. EGFR Positive UK does not endorse any companies, products or opinions that may be mentioned on this website.

 

© 2024 EGFR POSITIVE UK - Charity nº 1189722


PRIVACY POLICY

COOKIE POLICY